The investment climate surrounding Caribou Biosciences is fraught with tension. As this biotechnology firm pursues groundbreaking medical advancements with its...

The decision to postpone a critical special shareholder meeting regarding its planned acquisition by XenoTherapeutics has triggered a significant sell-off...

Could one therapy transform an underfunded biotech into a market leader? TG Therapeutics is making a compelling case with its...

Despite trading near its annual low, global professional services firm Marsh McLennan is making significant strategic moves to position itself...

Realty Income Corporation (O), the American real estate investment trust famously known as "The Monthly Dividend Company," has once again...

In a dramatic reversal of corporate strategy, food industry titan Kraft Heinz has announced plans to split into two separate...

Viking Therapeutics finds itself navigating significant market headwinds in the wake of recent clinical data presentations. The company's stock experienced...

Investors in Marine Products are facing a concerning contradiction: a seemingly attractive dividend yield exceeding 6% is being supported by...

As the healthcare sector continues to grapple with the opioid crisis, Pacira BioSciences has positioned itself as a dedicated provider...

Warner Bros. Discovery (WBD) finds itself navigating a perfect storm of corporate challenges, facing significant legal disputes and a notable...